Rogistgred number: 01835916 Charity number: 284881 PENNY BROHN CANCER CARE TRUSTEES. REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 ? Bishop Fleming PENNY BROHN CANCER CARE CONTENTS Page Refergncg and Administrative Details of the Charity. Its Trustees and Advisgrs Trusto05' R¢port Trusteos. Rosponslbllltles Statement 14 Ind8pendent Audltors. Report on the Financlal Statemonts 15-18 Consolldated Statoment of Financlal Actlvlths 19 Consolldatod Balance Sheet 20 Charity Balance Sheet 21 Consolidated Statement of Cash Flows 22 Notes to the Financial Statements 23-41 PENNY BROHN CANCER CARE REFERENCE AND ADMINISTFIATIVE D￿AlLs OF THE CHARrrf, rts TRUSTEES AND ADVISERS FOR THE YEAR ENDED 30 NOVEMBER 2022 Trustees Rev Dr Victor Barfey2 Jessica Brohn1,13 Rebecca Gmnoer3 Jacqueline Graves2 Jonalhon Green1 Ken Guy Iresigned 7 Octot*r 202211 Alex Hamillon-Baily2 Dr Pinelopi Kechag￿￿1Ou2 Stephen RosseM,3 Charles RusselkSmith1,3 Mohammed Saddiql Charfotie Whitei Finance & Audit Committee Peopk & Cufture Committee PB UK Commercial Ltd Director Company reglstered number 01635916 Charlty reglstered number 284881 Reglstered offlce Chapel Pill Lane Bristol BS20 OHH Company $¢cretsry Lisa Day (from 15 De￿mber 2022) Gail Boulton (until 14 December 20221 Chief executive offi¢¢r Andrew Hufford (from 1 De¢ember 2022) Julie Worrall (until 30 November 20221 Indopondont auditors Bishop Fleming LLP Chartered Accountants Slalulory Auditors 10 Temple Back Bristol BS16FL Page 1 PENNY BROHN CANCER CARE TRUSTEES, REPORT FOR THE YEAR ENDED 30 NOVEMBER 2022 Wglcom• to our 2022 Annual Report and Accounts for the period 1 Docomber 2021 to 30 November 2022 During 2022, desplte challenges, Penny Brohn UK continued to help more people with cancer feel better in control of their health and wellbeing through a rich and varied programme of cancer wellbeing Services. There were external pressures such as the continuing impact of the Covid-19 pandemic and increased energy costs, as well as many charities, including ours. experiencing challenges accessing funding. We are pleased lo report that the charity was able to continue offering hybrid services for people living wrth cancer throughout the year. The scope of online support Continued to expand providing trusted infoffftation. practical support, and a safe space for anyone with cancer. Online sessions are easily accessible for people unable to travel due to distance, level of illness or Incon￿ restrainl$. We have found a growing increase in geographical reach with more people finding their way to us through personal referrals and online content optimised for can¢er-wellbeing related search terms. With the safety of our dient's paramount, we introduced a range of in-person services al our National Centre at Ham Green near Bristol. These included Wellbeing Days and a small pilot of residential car)cer retreats. We also supplied counselling and complementary therapies at our Hub on the high street in central Bristol. Our ground-breaking partnership with Genesiscare continues to go from strewlh to strength. The partnership is an exemplar of how an integrative approach to cancer care can work in a medical Setting. Evaluation conlinues to show the incredible beneffts of an integrated approach to care for patients during Iheir tre8tment supporting improved quality of lrfe and better tolerance to treatmenl. Our income from hospttalty and retail operations continued to grow and exceed 2021 values, showlng an increased appelile for in-person meetings and events. We were also grateful to an anonymous donor who provided funding for us lo bw six acres of land nexl to our current propety and gardens. We are looking forward lo exploring how we can best use this land during the upcoming year. Due to a variety of pressures, the charity has posled a deficit this year and our financial sustainability is the main priority for 2023. The Trustees will be monitoting the situation carefully and our stsff and volunteers will continue to ensure our clients receive excellent supwrt while we build our income. By 2035, four million people in the UK will be living with cancer. A quarter of these will also be INing with the long-lerm physical or psychosocial impact of their cancerltreatment and will face significantly poorer quality of life. And so, an increasing number of people are aclivety I¢￿king for ways to support themsefves to have better control of their health and wellbeing. However. the lack of accessible sources of integrative cancer care provision in the UK mean5 that they are not able to find the help they need. As the leading cancer health and wdlbeing charity in the UK, our mission is lo help people feel better in mind, body, and spirit by empowering anyone wrth can￿r to lake an integrated and personalised apprgaoh lo their Care. We champion th? positiv? impact of personalised cancer cAre, enabling people living with cancer to find the support they need from our in-person and online setvices, and our self-help resources. Penny Brohn UK has over 40 years of experien￿ in working alongside people with cancer. We are experts in cancer wellbeing and integrated support, and our aim is to be the go-to charty for accessible personalised cancer care. On behalf of the Trustees: thank you to everyone who helps us work towards that vision, including our volunteers, supporters and partners. We are profoundty graletul for your support. Stephen Rosser Chair of Twslees Page 2 PENNY BROHN CANCER CARE TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2022 The Trustees of Penny Brohn UK have pleasure in presenting their report and financial statements fr)r the year ended 30th November 2022. Our Tepcrt includes the Directorfs report. The financial stateThnts comply wi(h the Charities Act 2011, Companies Act 2006, the Memorandum and Articles ofAssocialion and Accounting and Reporting by Charities., Statement of Recommended P￿ctICe applicable to charibes preparing their financial statements in accordance with the Fillancial Reporting Stsndard applicable in the UK and Republic of Ireland l(Charities SORP {FRS102)1. OUR ACHIEVEMENTSAND PERFORMANCE The Highlights We directy supported 2128 people with cancer through our Penny Brohn UK ServI￿S in 2022. Thls Is 1902 individuals joining group sessions, and 467 indwiduals using 1-1 sessions. On average, each person attended 5.9 sessions. These numbers are in addition to those supported through our partnership with Genesiscare. We developed our in-person SerV￿S and built on our 2021 Wellbeing Day pilot with the roll out of four themed days across the year. Held al our beautltul ￿ntre at Ham Green near Bristol, our llew monthly wellbeing days are an opportunty to meet others affected by cancer, enjoy some uplifting and inspiring sessions and a deliciously nutritious lunch. We also ran pilol Retreats our first residential offering since the pandemic- and ran eight of Ihese throughoul the year. Resource constraints means we may have to scale this back for 2023 but Y￿ are immensety proud to be opening our centre again for more of our important in-person Services. Alongside our in-person support, we also deltver a breadth of online support, and during 2022 our programme included over 20 informative andlor experiential sessions per week covering distinct aspects of our Whole Life Approach, including nutrition, exercise, yoga, Pilates, dan￿, relaxation, mindfulness, healing, hypnolherapy, tymphoedema support and resilience building. For those who need the accessibility that an online session provides: or those who simply prefer lo engage with support in this way, our sessions give valuable tips and strategies fr)r improved physical and emotional wellbeing. Thanks to the generosity of an anonymous donor, in 2022 we were able lo buy six acres of land next to our current propety and gardens. This Spa￿ will help us provide more of the therapeutic benefits -the 'magic' a5 ivs often called by our clients- lor people living with cancer. Our efforts lo diversrfy our income in 2021-22 fell short of our ambitions due lo the difficult funding environmenl for ¢harities and capacity gaps in our fvndrai5ing teams. A fundraising strategy lo remedy these issues is in progress. backed by the successful recruitment of strong candidates into key fundraising roles. That said, we successfulty generated £755,000, thanks to.. The on-going commitment and generosity of our core funders allowed us to continue the rollout of o(Jr online service model taknng us one step closer to a national support model. Generous £30k Trust and Foundation dollalion helping us further develop our community wellbeing and can￿r support offered at The Hub. Legacies still remain a vttal source of income for the charity, generating £154k, 20°h of our fundraising income. Over £330.000 was donaled through our generous individual donors, fundraisers, and regular gwers. We continued lo grow and refine our corporate fundraising strategy, stewarding and engaging new partners to generate vital fund5 to help towards expanding our in-person support. Page 3 PENNY BROHN CANCER CARE TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2022 Another highlight for 2022 was the utilisation of our assets. including the growth of our Hospitality income at the National Centre in Ham Green, and the continued success of The Hub, our charity shop and wdlbeing Space in Clifton. In these areas, income has grown consistently, which has been of great help during challenging financial times. The teams have worked hard to reopen our buildings after th8 pandemic, and it is wonderful to see people back in-person once again. WHAT WE ACHIEVED IN 2021-22 1. For everyone, everywhere °As a clinically vulnerable person I have lound the online sessions inv81uable. There 8re 8 V8riety of live sessions and webinans from which to choose and the yog8 and exercise c18SS8s have definitely aid8d my recovery. EverycN7e I've interacted with have been kind and consid6rale° In 2022. we continued lo offer servi￿5 kx)th in-person al our National Centre at Ham Green, and online, delivered virtually. Participants attended sessions from all across the UK, 9$ well as coming along lo the centre to meet and socialise in person. Our strategic vision is that everyone, everywhere can access personalised cancer care and we are pleased that through a hybrid approach we are able to deliver fantastic support regardless of location or accessibilty requirements. In person services An evaluation of our Wellbeing Day series de15V8red in 2022 found that client5 Tated their over811 experience as 4.8 out of 5, where 5 is eX￿lIent. One clienl told us that the day was a'Lovely, relaxing experience. A wonderful way to have a break from worrying about things.. In addttion, commenting on a retreat, a client said These few days have changed me intemally. I have been struggling so much with not just physical pain but also Stre55 and anxiety. This relreal has been invaluable. I have leamt $0 much and hope to take and use the toolkit in my daily life The One-lo-one appointments offered with our specialist Doctor team were also evaluated very highly, with the average rating 4.4 out of 5 for addressing the concems they came with: and 4.8 out of 5 for the doctor they saw. More than 80% of clients said they had experienced a positive change in their understanding and knowledge, their general wellbeing. and how confident and in control they felt. Online group sgrvicg$ In 2022, our Research & Evaluation team emtodded a rigorous process of Conlinuous Quality Improvement for our online group seNices. We asked a range of questions which nwrrored the charity's quality assurance framework and the oulcornes set out in our organisational Theory of Change. Through a series of Zoom polls and survey feedbackwe consisterrtly found that over 90% of clients found the sessions helpful, safe, trustsvorthy and encouraging. Finally, the annual evaluation report for our Treat￿nI Support Programme in May 2022 showed excellent results, including that 95QA of clients would recommend the prograrnme and 91 % reported feeling more confident aLKlUt getting through ¢ancer treatment. "I can honestly say that the Treatment Support Programme was without a doubt the best help I found al one of the worst limes in my lrfe and I will forever lje grateful to Penny 8rohn UK and the compassionate, hI￿WIedgeatsle, and understanding staff forproviding this seNice". 2. Our presence in the community While recogrbising the power of a hybrid approach, we continued to strengthen our presence in the community during 2022. Page 4 PENNY BROHN CANCER CARE TRUSTEES, REPORT {CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2022 In line wlh our strategy, and wth the safety of people with can￿r paraThJunl, our Setvices team ran pilols for in-person events in 2022. These were developed in response lo people asking for more physical connection and to complement the online programme of support Ihat was set up in 2020 and subsequently expanded. The pilots evaluated well, and we will continue to offer in-person wellbeing days in 2023 with a view to adding in residenlial retreats as and when sustainable funding becomes available. Our high-slreet Chartty Shop and Wellbeing space The Hub. has been open Since September 2020, and now into our second full year of trading we are seeing steadier footfall, reliable repeat custom and increasing sales week-on-week, which is reassuring for the year to come. as well as confirmation that there 18 space in the market and a desire for the model, the variety of services and products we have lo offer. In 2023 we will be starting to open on Sundays which will help us increase sales and opportunities to speak with custorners. In addition to the funds raised from the successfvl year of trade at The Hub, the benefrts of Ihe presence in a busy.. central cty location are endless. The retail team of staff and volunteers have a shared goal and work i focused and Structured way each week to keep The Hub at Ihe highest slandards of cleanlines5, merchandising and productivity, now Comfortably and con51Stenlly generating sales of between £1,500-£2,000 each week prior lo the additional value of Gift Aid and ecommerce sales from eBay and Depop, and an additional average of £200 per week from our online shop. The space also provides another way for people to access both Penny Brohn UK and private specialist therapie5. in a warm, welcoming environment that is easy to acces$ via public transport. Finally, our Fundraising team continued to work in the communty and built new relationships with local rotary clubs. schools and businesses as well as continuing existing partherships. Our annual Stomp fundraiser was another fantastic opportunity to bring the comrnunity together. 3. Ambitious for the future .1 reel so much more in control of my health and wellbeing. You have equipped me to deal with the totsgh times I know are coming." Our brand awareness increased during 2022, with an increase in the nUM￿r of new visitors to our websrte alld over 1500 new email sign ups. During 2022 we embarked on a review of our brand, and our organisalional strategy. We were keen to be ambttious and knk towards a luture where everyone was able lo feel in better ontrol of their health and wellbeing through ￿ncer. We have worked with Dan Dufour and Red Stone, sector leader5 at brand storytelling and creative work, and have consutled with our cu￿ent and earfier clients and partners at all stages of the process. A healthcare professional told us 'People think [Penny Brohn UK] is a bil loo alternative. and we worked hard to find a brand identity that appeals to a wsde range of people. whik keeping true lo the history of the organisation and Penny Brohn's original vision. Values of openness, slrength, ambition and joy were shown to work across both the services provided to people living with cancer, as wdl as our work inviting others to give support lo this vision in a variety of ways. We are proud to have heaTd from 8 wide range of voices as part of this work - both those who know Penny Brohn UK well, and others who have never heard of us. We spoke lo healthcare professK)nals, volunteers, can￿r charity CEOS and those who support us financialfy - from our major donors to our regular givers. We feel confident that this work will help us raise the profile of Penny Brohn UK and enable access to our services for more people living with cancer. We are mindful lo keep this work realistic and affordable. so we will utilise 2023 to plan the implementalion of our brand iderrtity- We are particularly focused on the ￿CesSibl11ty of our brand. and are committed to prioritising diversty, equlty and inclusion in our work moving forwards. In 2022. we worked with BeOnBoard. thanks to a generous donation in 2021 from The Prince of Wales's Charitable Fund, who reinforced the importance of equitable access lo cancer care and were pivotal to our strategy development wor Page 5 PENNY BROHN CANCER CARE TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2022 Working in PartngT¥hip 'With the fitness program from Genesiscare and the help from Penny Brohn UK it has been 8 lif8-changing experience for me. l am fitter and stronger than I have been for a long lime, exercising and walking daily, eating health￿r th8n l everh8ve and I have 8 drffe￿nt view on lrfe.. We work in partnership with organisations that share our vision that every person with cancer in the UK can access personali5ed cancer car8 for better outcomes and improved quality of life. Our partnership wÈth Genesiscare global leader in clinical oncology services has continued to develop and grow since its start in 2013. with further growth of 35% 12700 patients) this past y8ar. Furthermore, there has been a significant increase in patient interventions in thi5 period 158 /.). The team delivers personalised assessment and healthlwellbeing iF)formalion sessions, in addition to acupuncture, counselling, reflexology, and relaxation and mindtulness training. Working together to deliver an integrated approach to can￿r care, the Penny Brohn UK wellbeing team work closely wtth the Genesiscare Exercise medicine team, and we have evidence that our approach is clinically significant {81 0/0 first named Concern, 82 % second named concern.. Biannual Evaluation Report January 2023.) This report also shows that the service interventions reduce cancer treatment side effects by 60Y.. The Penny Brohn UK and Genesiscare partnership is a true example of integrative cancer care in practice, showing the best of clinical. lifestyle and evidence-based supportive therapies. Our latest evaluation report for the Genesiscare wellbeing services showed.. 600k of patients said the Penny Brohn UK wellbeing support had helped with tFeatrrEnt side-effects 89,10 of patients said the Penny Brohn UK wellbeing support had m8de a positive differen￿ to Ihe way they view their health and wellbeing 810/0 of palients had a dinically significant improvement in their main cancer related concern 660fi of patients had a dinicalty significant improvement in their wellbeing In collaboration with Genesi$Care a new online session was designed specifically for patients experiencing menopausal symptoms and induced menopause because of cancer treatment. This introduclory session supplied evidence-based information and symptom management recommendations in a clear and understandable format to 26 patient participants. 94¥0 of these attendees said they would recommend the service to someone else, and we kjok forward to improving this service in 2023. S. Expanding and utilising our therapeutic setting$ The aim In 2022 was to use our biggest asset, the Natlonal Centre and gardens, to increase Income through hospitality, venue hire, and subletting portions of the building. To carry out this aim we actively engaged wlth organisations and individuals in the wellness sector to promote the benefits of the house and gardens as a hospitality venue and a cooperative space for rent. And. for those looking to work out of a synergistic therapeutic space the opportunity to be part of a dynamic therapeutic hub. Hospltality income, which includes extemal bookings and room lets, grew over from 2021 levels (£12,000) to £227,000 in 2022. During the year we welcomed a wide range of synergistic activities including a recurring booking from Internal Family Systems Training, with its integrative approach to individual psychotherapy. The regional NHS Trusts made us their g￿t0 venue for training and meetings. We also welcomed the Terrain Advocate Program, training practitioners on a metabolic approach to cancer. At the beginning of the year, we were able to capitalize on an opportunity to use the centre as a filming venue for a popular paramount+ tv series, Flatshare. We have also been encouraged by the increase in sublets. The growing number of organisations and therapists working out of the centre brings a rich and diverse community of experts within the holistic wellness space. These include hypnotherapy. complementary therapies. talking therapies, and the leading mastectomy and post-surgery bra specialists in the UK- Nicola Jane. Page 6 PENNY BROHN CANCER CARE TRUSTEES, REPORT (CO￿lNUED) FOR THE YEAR ENDED 30 NOVEMBER 2022 Finally, a highlight was being able to purchase six acres of land adjacent to the National Centre in Ham Green, which will allow us to offer even more therapeutic space in the future. This will be a key area of focus for 2023 as we look at how best to utilise the land. OUR FUTURE PLANS Given our current financial position and the continuing pressures on the charity, we are acutely aware of the need for careful planning and prioritisation of activty. We remain ambrtious for the future, but our immediate focus in 2023 will be to scale our aclivty lo align with a sustainable income level, and to bring in as much unrestricted funding as we can. In 2023, we intend to do the following.. Focus on income generation to protect the services provision and continue to support people living with cancer, with a Coordinaled fundraising campaign through 2023. Carefully implement strategic and brand updates that will help increase awareness of the charity and encourage more people to SUPFX)rt us. Look al how the generous gift of six acreg of land adjacerrt to our National Centre can help us achieve our mission statements. Increase the amount of resources provided via our web5tte for people INing with cancer to access wheneverthey need. Our mission staternents We want to see a world in which everyone, everywhere can access per50nalised can￿r care. We are working to the following Mis￿on statements-. We will help you feel in better control of your heatth and wellbeing Ihrough cancer, with a range of personalised cancer care. Choose froTh eating well, keepnig active. managing your emotions, staying connected to the things you love, and much more. All provided by a team of healthcare experts. We'u also champion the positive impact of personalised cancer Ca￿ so mre people can benefft. Our purpose To help you feel in better control of your heafih and V￿lIbeing through cancer, physically and emotionally. Our values Our work is all underpinned by the following organisatlonal values- Ambitious for the future Vve believe in a future where everybody can access personalised cancer care for the mind, body and spirit. Whoever you are. However you are feeling. Vvhatever the cancer, including yours. Op9n to everyone Il's simply not right that so many people living with cancer do not curtenlty have access to personalised care that could help their quality of life. Every cancer story has ils own narrative. We celebrate individualty and all the unique things that make you. you. Finding the joy We understsnd all the pain and sadness that comes with a cancer diagnosis. 11 can be immensely emotional and overwhdming. Even through the darkest of days we have h￿e and find moments ofjoy. Page 7 PENNY BROHN CANCER CARE TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2022 Stronger together Remarkable things happen when we unite behind a shared purpose and values. So, we are proud to bring people together. Staff. supporters. specialists, healthcare professionals, and you. Penny Brohn UK defines personalised cancer ￿Te as: "Bringing togelh8r the best of clinical. lifeslyle, and evidence-based supportive therapies.. Whilsl clinical Inte￿entionS direclty I￿at the disease, complerrEntaryllrfestylelsupportive therapies can also.. Increase the physical and e￿L)th0nal resilience of the person with cancer. Reduce side effects that may be affecting quality of life. Increase tolerance of clinical treatments. meaning fewer delays to treatment schedules. Our new strategy will focus on developing a hybrid service delivery model that is universally avallable and wlll enable mcre people with cancer to access our support. We will increase our geographical and demographic reach and allow people to experience us in their worfds, to their schedules. A deep understanding of the needs of people wtth cancer, donors and partners will be at the wre of everything we do. We will be willing lo challenge our own thinking and to adapt historical ways of working, products, and setvices so that we can deliver the best practical solutions and experiences for those who engage with us. The positive impact of a personalised approach on people with cancer is shown consistently in our setvi¢e evaluations. Playing our part in addressing health inequalities is not onfy the right thing to do, but it will also enhance our value proposikn'on and we believe we have a mral responsibility to make a commitment lo supporting fair outcomes for all people with cancer. THANK YOU To all those using our services, who generously let us Into thelr liv85 and who continue lo in¥pirg us every day. All our philanthropists and corporate supporters. Our regular glvers who support us so generously, every person with cancer who has donated after an online session, every single supporter who left a gift in their will, has done a fundraising event in memory of a loved one or has bought a leaf on our Tree of Life. Our participants in the Bath Half Marathon. London Marathon. Bristol 10K and other running, walking and challenge events. Every supporter who shaved their head, baked cakes, or raised money in other creative ways is too many to mention. All those who took on our first Challenge 150 and attended Stomp. Everybody who shopped at the Hub or online or who donated goods for resale. Genesiscare, and our other partners, for their belief and commitment to people with cancer. Our dedicated, loyal and committed Trustee5, volunteers and staff who have continued to work tirelessly throughout the year to deliver the incredible results piesented in this report. We would also liko to thank: Walk the Walk Worldwide, Liz and Terry Bramall Foundation, Lillie Johnson Charitable Trust, ShareGift laka The Orr Mackintosh Foundation Ltd), The Eveson Charitable Trust, The Gerald Micklem Charitable Trust, The Frank Litchfield General Charitable Trusl, G M Morrison Charitable Trusl. The Blair Foundation, The Walter Guinness Charitable Trust, The Elizabeth And Prince Zaiger Trust. Inchcape Foundation, Florence Shute Millennium Trust, The Uxbridge CharIta￿e Trust. The Allen Charitable Trust, The 29th May 1961 Charitable Trust, The SoLrter Charitable Trust, lan Mactaggart Trust, Baron Davenport's Charity, The Eagle cha￿ty Trust, The Joseph Hopkins and Henry James Sayer Chanties, Nelsons, The Clark Foundation, Tim Tiley Bursary Fund, Gledswood Charitable Trust, The James TLEdor Foundation, Douglas Arter Foundation, Pink Ribbori Foundation, The Roger & Douglas Tumer Charbtable Trust. The Hilary Awdry Charitable Trust, St. James's Place Charitable Foundation, The Lawson TTUSt. John James Bristol Foundation, Sir Chades Jessel Charrtable Trust, The Vveinslock Fund, The February Foundation. The Gilander Foundation. Steven Cooper Charitable Foundation: Renishaw Charities Committee, Community Foundalion in Wales, The Annett Trust, Quartet Community Foundation Page 8 PENNY BROHN CANCER CARE TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2022 STRUCTURE. GOVERNANCE AND MANAGEMENT Penny Brohn UK is the working name of Penny Brohn Cancer Care (the charity) and is a company limited bwuarantee, registered on 17 May 1982. It 1$ govemed by Memorandum and Articles ofAssociation. Trustee Board Penny Brohn Cancer Care is governed by a Board of Truslees (the Board}. The Board's remit is lo set the vision. strategy and aims for the charity by rts objects. to manage the financial resources in the best interest of the charity and its benef￿larieS and to ensure the charity works in a manner consistent with its objectives. The Board met forma15y seven times during 2022, four times in petson and three times TenTh)te￿ via Zoom. The Finance and Audil Committee met four times remotely. The People and Culture Committee mel twice molely. The Commercial Committee met three times remotety. In 2023 we will increase the number of sub- committees from three to five, to enable us to further develop our service delivery and our fundraising propositions and income. Trustee appointment. induction and training Trustees are appointed to supply the skills identified as being necessary for the good governance of Penny Brohn Cancer Care. There is a formal recruitment process for finding new Trustees and once appointed, an induction and training process. The induction of new Trustees is tailored to the needs of the individual but includes the provision of key documents and information relating to the charity, a guided tour of the National Cenlre, introduction to the Chair. Executive Team and other key staff and on outline of the duties. responsibilities ar)d obligations of being a Trustee. Tnjstees are encouraged to attend external and internal development events where it is felt these will help the execution of their governance role. The term of office as a Trustee is a three-year period and Trustees may serye up to three terms, except in exceptional circumstances, when the term of Offi￿ can be longer. All Trustees give their lime voluntarily and recenie no payment or benefits from the charity- Trustees must show all relevant interests avd Tegister them with the CEO and withdraw from decisions where a potential conflict of interesl might arise. Any expenses reclaimed or related party transactions in the year are set out in note 24 to the financial statements. Key management The Board delegates the day-lo-day running of the charity to a Chief Executtve Officer and an Executive Team who report to the Board on a forrnal: regulai basis. The team is wholly comprised of non-statutory directors namely the CEO: Commercial Director and Director of Strategy and Insight. Public beneflt The Trustees of Penny Brohn Cancer Care ensure that the charity carries out ils aims and objectives and that these supply public benefil. In doing so the Trustees take inlo wnsideration the Charity Commission's guidance on the Public Benefit requirement under the Charities Act 2011. Our charitable purpose The charitable aims of the ¢harty. as set out in th6 Articles of Association, are to advance health and to relieve sicknes5 and dislress, especially but not exclusively about cancer and those affected by it, by such means as the Trustees in their discretion shall decide. Pay policy The pay and reward of the Executive Team is subject to the same structure as used for employees and is In line with the Executive Pay Policy. This policy is regularly reviewed by the People and Culture Committee with the support of the Trustee Board. The pay and reward of the CEO is reviewed by the Chair (in agreement with the full Trustee Board). There were 49 (2021- 48) full-time equivalent employees during the year. Trading Subsldiary The charity has a wholly owned trading subsidiary, PB UK Commercial Ltd, which passes all its t8xaNe profit by way of Gift Aid to further the aims ofthe Charty- PB UK Commercial Ltd has a Board of Directors, which during the year under review consisted of four Trustees. Penny Brohn Cancer Care owns the entire share capital of the subsidiary. Page 9 PENNY BROHN CANCER CARE TRUSTEES, REPORT (CONTINUED FOR THE YEAR ENDED 30 NOVEMBER 2022 Risk Management The Trustees have adopted a risk management strategy whith includes- A risk policy, approved by Ihe Trustees and Subject to annual review. The maintenance of a strategi¢ risk register to review the risks the Charity may face. and the mitigating actions the Charity has taken or can take. The risk register 15 reviewed at Trust8e meetings and risks are scored in terms of both impact and likelihood. Systems, policies, and procedurés designed to minimise impact on the Charity should those risks occur. Slrateglc Rlsk Register strategic risks are signrficant i&3that infiuence the achievement of the Charity's Core aims. They mighl be major intemal risks such as financial sustainability or compliance risks. Or they may be extemal events with high Irnp￿t which we cannot contrd and to which we therefore need to respond. During 2022 key strategic risks were identified as.. Financial 8U8tainability: this is mitigated by a robust forei*sting and business planlling process, a strong balance sheet and the availability of a £1 million revolving credit facility. We conlinue lo diversify our income streams, focusing on sub-leth'ng business space within the National Centre to synergistic organisations, to ensure we are not too reliant on one source of income. We are creating a fundraising sub-committee as part of our strategic development. Impact of cli8nt services- We must ensure w8 are investing in the Tight and most relevant services to make maximum impact. We are mitigating this risk by ensuring we ¢onlinue to develop a user voice programrne and embed it in all we do. We are also embedding a quality assurance programme and improving the qualty of the data we collect and hold Strategy development work and the underlying identification and testing will support our ability to invest in the services that wll make maximum impact on people with cancer. We are also creating a services governance sub-committee. staff Impact. A reduced core team has resulted in capacity issues across the organisation. We are mf(igating this risk through the use ofzero-hour stsff lin Hosprtalityl, the development of a volunteer strategy lie Reception volunteers) and outsourcing for specialisUprofessKJnal skills. Cost of utllitles: The cost of energy over the coming year is going to increase fourfold and therefore have a big impact on the charity finances. This is being mrtigaled by making staff aware of their energy use whilst al the National Centre and we are working closety wrth an energy broker and external green energy consultant to explore how we can improve our enew efficiencies. Fundraising standards The Trustees are aware of current legislation and updated guidance from Ihe Charity Commission. Penny Brohn Cancer Care is a fully contributing member of the Fundraising Regulator and Institute of Fundraising. We adhere to the Codes of Fundraising Practice in all activities. We are fully compliant with the regulations where it applies to us. We do not ¢onlra¢t with third party fundraising organizations. We are committed to best practice in all areas of fundraising activity and are dedicated to delivering transparent, effective, and ethical fundraising. Our supporters are at the heart of our fijndraising, and we take our responsibilities to them, and our relalionships with them. very seriously. Staff We continue to develop a strong engagernent with our staff team. Our staff have shown remarkable resiliencethroughout the year with financial ChaI￿ngeS and a continuation of remote working where appropriate. Page 10 PENNY BROHN CANCER CARE TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2022 Working with voluntèers 2022 showed a steady increase in volunteer activty following the impact on many roles by the pandemi¢. We have been pleased lo welcome volunleers back regularty to the National Centre in some of our supporting and administration roles white others are now fully operational from home and embracing our hybrid working model. The Services team in particular have benefited from volunteer support providing online client sessions a5 part of the charitys digital offering. An approximate 4,150 volunteer hours were worked including the well4stablished garden te8m who have continued lo keep the Penny Brohn gardens looking their best all year round for everyone to enjoy. In addition, a newly formed team at the Penny Brohn Hub have ensured that the retail operation runs Smooth￿ six days per week with plans for a 5even-day opening in 2023. These roles along with all the other3, help the charity to make a valuable saving in staff wages. The year ahead will see new opportunities as we bring a volunteer ReCept￿n team into the national centre and look to support the work of the charity in other areas such as Client Support and Fundraising. As always, we will continue lo rety on the support of our event volunteers who turn out come rain or shine to ensure that events such as Open Garden Day and Stomp are a big succes5. We recognised the very valuable contribution made by all our volunteers and are thankful for their ongoing Support. Cllnl¢al governance Clinical governance refers to assuring the safety and quality of our client facing services which include fa¢e-to-face, virtual. remote and online resources. Effective quality assurance enables us to ellsure that our service5 are safe. caring. fair. well-led and responsive to clienl needs. Penny Brohn Cancer Care has developed a clinical govemance framework which ensures that clients receive the best and safest care possible. In addition, the charity plans to set up a clinical and scientific advisory panel made up of relevant academic and clinical experts from both within and outside of the charity who will supply scrutiny and advice on the clinical governance of the charity's services. FINANCIAL REVIEW Statement of Financial Affairs (SOFA) During the year, the Charty received £2.2m in unrestricted income12021= £2.1 ml. Reslricled income of £115k 12021: £185kl was donated resulting in total income £2.3m (2021.. £2.3m). Major sources of funding We￿ received from: 2022 2021 £000 Grant makers Personal donations Legacies Community fundraising aclivities and events Strategic partnerships Corporate donations Retail HOs￿laI1fy 256 494 182 145 756 300 342 475 178 668 99 23 Legacy income for the year was £182k. We received a donation of £257k from an anonymous donor to enable us to purchase the new land. Page 11 PENNY BROHN CANCER CARE TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED 30 NOVEMBER 2022 Income from grant makers included £1 Ook from Walk the WalL a bng-slanding supporter and funder of Penny Brohn Cancer Care. Expenditure in the yearwas £2.8m {2021'. £2.2m). Staff costs were £2.Om12021.' £1.7m). We closed the year with a deficit of£564k {2021'. surplus of £47k>. Balance Sheet Our National Centre based in Ham Green, near Bristol. was valued in 2019 at£6.1m. We spent £9k on computer equipment during the year and wrote off £41 k of fully depreciated fixtures, frttings and IT equipment. Consolidated current assets fell to £691 k compared to £1,452k in 2021. Cash balances also redu¢ed from £1.1m in 2021 to £332k. Gurrent liabilities increased to £341 k from £286k. Long term liabilities reduced from £947k in 2021 to £925k due to repayments on the mortgage and bounce back loan, which was drawn down in December 2020. Our ¢losing reserves position is £5.8 million. The funds are itemised below. Our General Fund also known as Free Reserves closed at £191k. £OOO's 5.269 191 (t2) 55 375 Capital Fund General Fund (Free reserves) PB UK Commercial Ltd Revaluation Reseive Restricted Funds PB UK Commercial Ltd The trading subsidiary carries out all the trading actrvthes of Penny Brohn Cancer Care. The trading subsidiary manages all room hire and associated services at the National Centre. The fomier shop opened as a visitors, centre offering infonnation to clients as well as selling goods such as books, nutrition items and body care products. Trading activity during 2022 was £237k 12021: £65k). PB UK Comn*rcial Ltd did not generate sufficient profits during 2022 to enable a donation lo be made under deed of covenant to Penny Brohn Cancer Care (2021.. £Nill. Reserves policy Group reserves on 30 November 2022 amounted to £5.8m (2021.. £6.3m} of which £5.3m related to the capital fund12021.. £5 1 m). £375k are restricted funds12021- £212k). Restricted ￿ndS are itemised in note 20 of the rinancial slatements. Penny Brohn free reseNes have decreased from £1m in 2021 to £191 k. The decrease in reserves was in breach of the stated Trust poltcy but was noted, agreed and monitored by the Trustees through Ihe latter part of 2022 as costs rose and in￿rne underperformed, resulting in the 2022 financial position and subsequent loss. The ¢h8rities intention is to draw down ov agreed loan facilities to mainlain liquidity and to review and set a revised resetves policy whilsl maintaining ¢￿se scrutiny of the cash flow of the organisation. In light of the currer)t financial position and the lengthy period that it will take for the charity to return to stable position, and Iherefore to avoid excess borrowing the Twstees have decided to reduce the ￿selVeS policy to an amount that equate to 1.5 times Month￿ predicted payroll namety £330.000. Going Concern The Finance and Audit Committee regularty review financial reports from the Charity, including forecast cash flow scenarios. to attest positively lo the Charity's going concem status. This review is shared with the full Trustee Board at each Trustee meeting. Page 12 PENNY BROHN CANCER CARE TRUSTEES. REPQRT (CONTINUED) FOR THEYEAR ENDED 30 NOVEMBER 2022 The charity has two committed loan facilities, both secured on the National Centre.. A mortgage of £1 m with Nalwest Bank. The mortgage has a ten yearterm and an Inte￿$1 rale of3.42 10. The Charity also has revolving loan facilib'es of up lo £500k with Triodos Bank and £500k with Natwest. Neither was utilised during the year. We have excellent business relationships NatWe$t and Triodos. The charity intends to continue to hold these temi debt facilities and to draw down £200,000 from each of the facilities in early 2023 to ensure liquidity of the organisation. The charity drew down a £50,000 Bounce Back Loan in December 2020, to aid cash flow over the winter of 2020121. The loan has a five year lerm and an interest rate of 2.5°/o. The loan is 1000/0 guaranteed by the Government and repaymenls commenced in December 2021. The Trustees have a structured approach to the financial strategy of the charity. which includes a three -year plan reviewed by Tnjstees annualty from which the 12-month budget and cash flow forecast is prepared. Quarterly forecasts are also prepared. The Trustees review and monitor the budget and cash flows al each Trustees meeting, interrogating variances. This continuous monitoring and control ensure the Trustees can properfy rewew the charity's going concem status and its financial viability. The Trustees review the charivs forecasts and projections at each Finance & Audit Committee and Board meeting and have a reasonable expectation that the charity has adequate resources lo continue in operational existence for a period of at least 12 months following the date of approval of these financial statemerbls. The group therefore continues to adopt the going concem basis for preparing its consolidated financial statements. Disclosure of infomiation to thè audltors In 50 far as the Trustees are aware.. there is no relevant audit infomialion of which the chartkable company's auditor is unaware., and the Trustees have taken all steps required to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information. Approved by order of the members of the Board of Trustees and signed on their beha￿, by.. Stephen Ros$8r Chair Date., Page 13 PENNY BROHN CANCER CARE STATEMENT OF TRUSTEES. RESPONSIBILMES FOR THE YEAR ENDED 30 NOVEMBER 2022 The Trustees {who are also the direc*ors of the Charity for the purposes of company lawl are responsible for preparing the Trustees, Report and the financial statements in accordance with applicable law and United Kingdom Accourbting Standards {United lQngdom Generally Accepted Accounting Practice). Company law requires the TTUStees to prepare financ4al statements for each financtal . Under company law, the Trustees musl not approve the finarboal statements Lsnless they are satisfied that they give a true and fair view of the stste of affairs of the Group and the Charity and of their incoming resources and application of resources, including their income and expenditure, for that perh)d. In preparing these financial stslements, the Trustees are required to.. selecl 5Ultable accounting policies and then appty them eonsistently., observe the methods and prinaples of the Charities SORP {FRS 102); make judgements and accounting estimates that are reasonable and prudent., state whether applicable UK Accounting Standards IFRS 1021 have been followed, subject to any material departures disclosed and explained in the financ￿1 statements., prepare the financial statements on the going concem basis unless rf( Is inappropriate lo presume that the Group will continue in business. The Trustees are reswnsible for keeping adequate accounting records that are Suff￿lent to show and explain the Group and the Charity's Iransact'ons and disclose with reasonable accuracy at any time the financial position of the Group and the Charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Group ar¢d the Charity and hence for taking reasonable steps for the prevention and deteth.on of fraud and other l￿egUlarl11es. Approved by order of the members ofthe Board of Trustees and signed on its behalf by.. Stephen Rosser Chair of Trustees Date.. ti- Tr- Is Page 14 PENNY BROHN CANCER CARE INDEPENDENT AUDITORS. REPORT TO THE MEMBERS OF PENNY BROHN CANCER CARE OPINION We have audited the financial statements of Penny Brohn Cancer ca￿ (the 'pa￿nI charitable company'l and its subsidiaries (the 'group'l for the year ended 30 November 2022 which comprise the Consolidated Statement of Financial Activities, the Consolidated Balance Sheet, the Charity Balance Sheet, the Consolidated Statemènt of Cash Flows and the rdated notes, induding a summary of significant accounting policies. The financial ￿porting framework that has teen applied in their preparation is applicable law and United ￿ngdoM Accounting Slgndards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of I￿land, (United Kingdom Generally Accepted Accounting Practice). In our opinion the finanoal statements.. give a true and fair view of the slate of the Group's and of the parent charitable company's affairs as al 30 November 2022 and of the Group's incoming ￿sOurCeS and application of ￿SoUrces. including ils income and expenditure for the year then ended", have been properly p￿Pared in accordan￿ wtth Unrted Kingdom Generally Accepted Accounting Practice., and have been prepared in ac(x)rdance with the requirements ofthe Companies Act 2006. BASIS FOR OPINION We conducted our audit in accordance with Internalional Standards on Auditing IUKI IISAS IUIfjI and applicable law. Our responsibilities under those standards are fvrther described in the Auditors, responsibilities for the audit of the financial statements section of our report. We a￿ independent of the Group in accordan￿ with the ethical requirements that are relevant lo our audit of th8 financtal statements in the United Kingdom, including the Financial Reporting Council's Ethical Slarmjard, and we have fulfilled our olher ethical responsibilities in accordance with these requirements. We believe that the audil evKlence we have obtained is sufficient and appropriate to provide a basis for our opinion. CONCLUSIONS RELATING TO GOING CONCERN In auditing the financial statements, y￿ have concluded th* the Trustees. use of the going Con￿rn basis of ac¢ounling in the preparation of the financial statements is appropriate. Based on the work we have perfomied, we have not idenlffied any material uncertaintie5 ￿lating to events or conditions that, individually or collectively, may cast sNJnificanl doubt on the Group's or the parent charitable company's ability to continue as a going o)ncem for a peri¢JJ of at least tWe￿e months from when the financial statements are aulhorised for issue. Our responsibilities and the responsibilikn'es of the TNstees with respect io going concern are described in the relevant sections of this report. OTHER INFORMATION The other information comprises the information included in the Annual Report other than Ihe financial Statements and our Auditors, Report thereon. The Trustees are resFJon5ible for the other information contained within the Annu￿ Report. Our opinion on the finanaal statements does not cover the other information and, except to the extent otherwise explicf(ly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other infomiation and, in doing so, consider whether the other information Ts Tnalerially inconsistent with the finanual statements or our knowledge obtained in the course of the audit, or otherwse appears to be materialty misstated. If we identify such material inconsistencie5 or apparent material misstatements, we are required to detemine whether this gives rise to a material misstatement in the financial statements themselves If, based on the work we have perfonned wè conclude that there is a material misstatement of this other information, we are required to report that facl. We have nothing to report in this regard. Page 15 PENNY BROHN CANCER CARE INDEPENDENT AUDITORS. REPORT TO THE MEMBERS OF PENNY BROHN CANCER CARE ICONTINUEDI OPINION ON OTHER MArrERS PRESCRIBED BY THE COMPANIES ACT 2006 In our opinion, based on the work undertaken in the course of the audf('. the infomiation given in the Trustees. Report for the financial year for which the financial statements are prepared 15 consistent with the financial statements. the Trustees, Report has ken prepared in accordan￿ with applicable legal fequirements. mA￿ERs ON WHICH VVE ARE REQUIRED TO REPORT BY EXCEPTION In the light of our knovAedge and understanding of the charttable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Tru5tees' RepoTL We have nothing to report in respect of the following matters in relation to which Companies Acl 20CX% requires us to report to you if, in our opinion.. the parent chariiable company has not kept adequate and sufficient accounting records, or returns adequate for our audit have T￿t been received from branches not visited by us., or the parent charitable company ffnancial ststements are not in agreement with the accounting records and returns,. or certain disclosures of Trustees. remuneration speciffed by Law are not made,. or we have not received all the inf0m￿li0n and explanations we require for our audit RESPONSIBILITIES OF TRUSTEES As explained more fulty in the Trustees, ReSponsibil￿eS Statemen( the Ttustees (who are also the directors of the charitable company for the purposes of company lawl are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is lle￿ssary lo enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the Trustees are reswnsible for assessiny the Group's and the parent charitable compan*s ability to continue as a going concern, disclosing, as applicable, matters ￿ lated to going concem and using the going concem basis of accounting unless the Trustees eiiher intend to liquidate the Group or the parent charitable company or to ￿ase operations. or have no realistic altemative but to do so. Page 16 PENNY BROHN CANCER CARE INDEPENDENT AUDITORS. REPORT TO THE MEMBERS OF PENNY BROHN CANCER CARE ICONTINUEDI AUDrroRS' RESPoNSIBIL￿lEs FOR THE AUDft OF THE FINANCIAL STATEMENTS Our objeGtwes are to obtain reaSona￿e assuran￿ abolrt wh9ther the financial statements as a whole are free from material mi55tatement, whether due to fraud or error. and to Issue an Auditors, Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit ¢ondu¢ted in accordance with ISAS IUKI will thays delect a material misstatement when il exists. Misstatement$ ¢an arise from fraud or error and are considered material rf. individualty or in the aggregate, they could reasonably be expected lo influence the econornic decisions of users taken on the basis of these financial statements. Irregularities, including fraud, are iTrstan CASH FLOWS FROM INVESTING ACTlVtnES Pur¢ha$e of tangible fixed assels 181 NET CASH USED IN INVESTING ACTivmES 13481 {81 CASH FLOWS FROM FINANCING ACTivmES Cash inflows from new bO￿OWIng Repayments of borrowing Interest Paid 50 1311 1251 {33) {45} NET CASH USED IN FINANCING ACTivrnES 178) CHANGE IN CASH AND CASH EQUIVALEpifs IN THE YEAR (143) 1,075 Cash and rAsh equivalents al the beginning ofthe year 1,080 CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR 332 1,075 The note5 on pages 23 to 41 form part of these financial State￿nts Page 22 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 GENERAL INFORMATION Penny Brohn Cancer Care is a charity registered in England and Walos and a Company limited by guarantee. It was incorporated on 17 May 1982 {company number 016359161 and registered as a charity on 30 June 1982 (charity number 2848811. Penny Brohn UK is the worknng name of Penny Brohn Can￿r Care. The company was established under a Memorandum of Association which established the objeGts and powers of the charitable company and is govemed under its Articles ofAssociation. ACCOUNTING POLICIES 2.1 BASIS OF PREPARATION OF FINANCIAL STATEMENTS The financial ststements have ijeen prepared in accordance ￿th the Charities SORP (FRS 1021 Accounting and Rewrting by Charitses.. Statement of Recommended Practice applicable lo charities preparing their accounts in accordance the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021 {effective 1 January 20191, the Financial Reporting Standard applicable in the UK and Republic of IreLand IFRS 1021 and the Companies Act 2006. Penny 8rohn CanrEr Care meets the definrtion of a public benefit entity under FRS 102. Assets and liabilib'es are initially recognised at historical cost or transaction value unless otherwise ststed in the relevant accounb'ng policy. The Consolidated Slaternent of Financial Activities {SOFA} and Consolidated Balance Sheet consolidate the financial statements of the Charity and its subsidiary undertaking. The results of the subsidiary are consolidated on a line by line basis. The Charity has taken advantage of the exemption allowed under sects.on 408 of the Companies Act 2006 and has not presented (ts own Statement of Financial Ath"vities In these finaricial slatemenls. 2.2 GOING CONCERN The Charity's forecasts and projections show that the Charity expects to operate within the level of its current debt facility. As detailed in the annual ￿port, the Charity seeks to increase inwme from fundraising to enable more people to a￿sS free support to help them live well with cancer, and allow us to influence the healthcare agenda. The Finance & Audit Committee regularty review various relevant financial rèports from the Charity, including fO￿tast cash flow s(*narios: to attest positively to the Char7ty's going concern status. This review is shared wrth the full Trustee Board at each Trustee meeting. The Charity has committed k)an fa(xlities. It pLans to continue to hold Ihese term debt facilits'es, secured on the Nabonal Centre, that are used io bridge timing gaps in revenue rak*ing. The Charity received a £50.000 Bounceback k)an in December 2020. The loan is 100 /0 guaranleed by the Government repayments commenced in December 2021. Page 23 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 ACCOUNTING POLICIES (contlnued) 2.2 GOING CONCERN (CONTINUED) The Trustees have a structured approach to the financial strategy of the Charity, which includes the 5 year plan reviewed by Trustees annually from which the 12 month budget and cash flow forecast is prepared. QUarte￿Y forecasts are also prepared. Trustees review and monitor the budget and cash flows at each Trustees meeb"ng. inlerrogabng vanances. This continuous monitoring and control ensures the Trustees are able to properfy review the Charl￿S going concern status and its financial ability. The Trustees review the ChariVs forecasts and projections at eath Board meeting and have a reasonable expectation that the Chanty ha5 adequate resources to continue in operational existence for a penod of al least 12 months f￿lowIng the date of approval of these financial statements. The Group therefore continues to adopt the going concem basis for PT8partng its consolidated financial statements. 2.3 INCOME l income is recognised once the Charity has entitlement to the income. il is probable that the income will be received and the arrv)unt of income receivable can be measured reliably. The recognition of income from legaues is dependent on establishing entitlement, the probability of receipt and the abilty to estimate with suffiaenl accuracy the amount receivable. Evidence of entitlement to a legacy exists when the Charity has sufficient evidence that a gift has been left lo them (through knowledge of the e￿stenCe of a valid will and the death of th& benefactorl and the executor is sab'sfied that the property in question will not be required to satisfy claims in the 8slale. Re￿Ipt of a leg￿Y must be recognised when it is probable that il will be re￿iVed and the tsir value of the amount receivaNe, which wll generdlly be the expected cash amount lo be clistributed to the Charity, can ￿ reliably rneasured. Other income is recognised in the perTod in which it is receivable and lo the extent the goods have been provided or on completion ofthe seNce. 2A EXPENDITURE Expenditure is recognised On￿ there is a legal or constructive obligation to transfer economic benefit to a third paty, il is probable Ihal a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. ExpendÉture is classified by activity. The costs of each activity are made up of the total of direct costs and shared.costs, including support costs involved in undertaking each activity- Direcl costs attributable to a single activity are allocated directly to that acb'vity- Shared costs wh￿h contribute to more than one activity and support costs which are not attributable to a single activity are apwrboned between those activtties on a basi5 consistent with the use of resources. Central staff costs are allocated on the basis of time spenL and depreciation charges allocated on the portion of the aS￿S use. Expenditure on raising funds includes all expenditure incurred by the Group to raise funds for its aritable purposes and includes costs of all fundrdiSin9 ath"vib'es events and non￿arl￿ble trading. Expenditure on charitable acb"vib"es is incurred on directly undertaking the activities which further the Group's objectives, as well as any asswated support costs. l expenditure is indusNe of irrecoverable VAT. Page 24 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 ACCOUNTING POLICIES {contlnued) 2.S INTANGIBLE ASs￿s AND AMORTISATION Intangible assets costing £500 or more are capitalised and recognised when future economic benefrts are probable and the cost or value of the asset can be measured reliably. Intangible assets are initialty re¢￿nised at cost After recognition, under the cost model, intangible assets are measured at Cost less any accumulated aM0￿SatiOn and any accumulated impaiTrnent losses. Amorb'sation is provided on the followng bases.. Website Computer So￿are 25Y. 20Y. 2.6 TANGIBLE FIXED ASS￿$ AND DEPRECIATION Tangible fixed assets costing £500 or more are capitalised and recognised when fvture economic benefrts are probable and the cost or value of the asset can ￿ ￿￿aSured reliably. Tangible fixed assets are inf(ialty recognised al cosL After recognits"on, under the cost Tnodel, tsngible fLYed assets are Measured at cost les5 accumulated depreciakn.on and any accumulated impairment losses. Al costs incurred to bring a lang11￿e ffixed asset into ils intended working condTtion should be included in the measurement of cosL Depreciation is charged so as to allocate the cost of iangible fixed assets less their residual value over their estimated useful lives, using the straight4ine Method. Depreciation is provided on the following basis.. Freehold propety Long-lerm leasehoEd propety Fixtures and fittings Computer equipment based upon the length of the lease 10¥0 20% 2.7 INVESTMENTS Fixed asset investments are a forn of finanryal instrument and are initially recognised at their transaction cost and subsequently Tr￿aS￿red al fair value at the Balance Sheet date, unless the value cannot be measured reliably in which case i( is measured at cost less impaim)ent Investment gains and losses, whether realised or unrealised, are combined and presented as 'GainsllLossèsl on investments, in the Consolidated Statement of Finanaal Activities. 2.8 STOCKS Stocks are valued al the k)wer of cost and net realisable value after making due allowance for obsolete and slow4Th)wng stocks. Cost indudes all direct costs and an appropriate proportion of fixed and variable overheads. 2.9 DEBTORS Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaTrd net of any trade disLounis due. Page 2S PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 ACCOUNTING POLICIES Icontlnuod) 2.10 CASH AT BANKAND IN HAND Cash at bank and in hand includes cash and short-term highty liquid investments with a short maturity of three months or less from the date of acquisition or oFening of the deposit or similar account. 2.11 LIABILITIES AND PROVISIONS Liabilities are recognised when Ihere is an obligation at the Balance Sheet date as a result of a past event: it is probable that a transfer of economic benefit will be required in settlement, and the amount of the setuement can be estimated reliably. Liabiltties are recognised at the amount that the Charity anticipates it will pay lo setue the debt or the amount il has received as advanced payments for the goods or services tt must provide. Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is rwnised in the Consolidated Statement of Financial Activities as a finance cost. 2.12 PENSIONS The Group operates a defined contribution pension scheme and the pension charye represents the amounts payable by the Group to the fund in respect ol the year. 2.13 FUND ACCOUNTING General funds are unreslricled funds which are available for use at the discretion of the Trustees in fijrtherance of the general objectives of the Group and which have not been designated for other purposes. Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim ané use of each destgnated fvnd is set out in the notes to the financial statements. Restricted funds a￿ fijnds whth a￿ to be used in accordan￿ with specific restrictions imposed by donors or which have been raised by the Group for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial stalements. Investment income, gains and kjsses are all￿ated to the appropriate fund. CRITICAL ACCOUP￿ING ESTIMATES AND AREAS OF JUDGEMENT Estimates and judgements are continually evaluated and are based on historical experience and other faclors, including expectations of fviure events that are believed to be reasonable under the circumstsnces. Critical accounting esl'mates and assumptions" The Group rnakes estimates and assumptions con￿mIng the future. The resulting accounts'ng estimates and assumpb'ons will, by definition: seldom equal the related actual results. The Group do not consider there to be estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilitses. Page 26 PENNY 8ROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 INCOME FROM DONATIONS AND LEGACIES Unrgstrlctod Rastiicted funds funds 2022 2022 £000 £000 Total funds 2022 £000 Total funds 2021 £000 DONATIONS General donations Donations from the Friends of Penny Brohn Cancer Care Land donations Legacies 507 115 622 825 60 257 182 60 60 257 182 475 115 1.121 1,360 TOTAL 2021 1,175 185 1,36Q INCOME FROM CHARITABLE ACTivmES Unrestricted funds 2022 £000 Total funds 2022 £000 Total funds 2021 £000 Service generated income from partherships Other service generated inco￿￿ 756 28 756 28 672 30 702 Page 27 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 INCOME FROM OTHER TRADING ACTNMES Incom¢ from non ¢harltablè tradlng aethittl•g Unrestrlcted funds 2022 £000 Total funds 2022 £000 Total nols 2021 £000 P8 UK Commercial Income FaGilib'es income The Hub 237 39 93 237 39 93 65 12 71 369 369 148 OTHER INCOMING RESOURCES Unrestrlcted funds 2022 £000 Total funds 2022 £000 Total funds 2021 £000 CJRS recovery grant 75 EXPENDITURE ON RAISING FUNDS FUNDRAISING TRADING EXPENSES Unre$trlcted funds 2022 £000 Total funds 2022 £000 Total funds 2021 £000 Fundraising Wages and salaries Pension I￿sts 69 69 284 11 72 241 11 364 364 324 Page 28 PENNY BROHN CANCER CARE NOTES TO THE FINANCLAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 EXPENDITURE ON RAISING FUNDS ICOKllNUEDI OTHER TRADING EXPENSES Unrostrfctsd funds 2022 £000 Total funds 2022 £000 Total funds 2021 £000 Trading expenses - PB UK Commercial Ltd and The Hub 69 69 ANALYSIS OF CHARITABLE ACTivmES Actlvltles undertaken dlw¢tly 2022 £000 Total funds 2022 £000 Total funds 2021 £000 Face tD Face and Remte servi￿ delivery Administration Communications Partnerships Facilities 478 478 567 188 637 807 563 116 106 253 188 637 535 535 2,405 2,405 1,845 10. AUDITORS. REMUNERATION 2022 £000 2021 £000 Fees payable to the Charitys audttor for the audf( of the Chanty's annual accounts 15 13 Page 29 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 11. STAFF COSTS Group 2022 £000 Group 2021 £000 Charlty 2022 £000 Charity 2021 £000 Wage5 and S￿a￿e5 Social security costs Contribution to defined contributh)n pensTron schemes 1,774 140 1,411 103 1,774 140 1,411 103 83 68 83 68 1,997 1,582 1,997 1,582 Redundancy costs in the year an￿￿￿ted to £52,68612021.' £5.9321. The average number of persons employed by the Charty during the yearwas as follows.. Group 2022 No. Group 2021 No. staff 64 87 The average headcount expressed as fijll-time equivalents was.. Group 2022 Group 2021 Delivery of face to face and remote client services Fundraisiny and trading Finance and administration Facilib'es The Hub 26 10 49 48 The number of employees whose employee beneffts (exduding empkiyer pension Costs) exceeded £60.000 was,. Group 2022 No. Group 2021 No. In the band £60,001- £70,ODO In the band £70,001- £80,000 The key management personnel of the group and parenl charity compNse the Trustees, the CEO, Commercial Director and the Director of Strategy & InS￿ht. The total employee benefits of the key management personnel of the thanty for the year was Q06,840 12021.. £302,770), including social security costs of £23,28912021'. £29,493). Page 30 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 12. TRUSTEES. REMUNERATION AND EXPENSES During the year, no Trustees received any remuneration or other benefits12021- £NIL}. During the year ended 30 November 2022, expenses totalling £114 were reimbursed to l Trustee (2021.. £54}. 13. INTANGIBLE ASSETS GROUP AND CHARITY Computer software £000 Palents £000 Total £000 COST Al 1 D￿rnber 2021 39 86 125 AI 30 November 2022 39 86 125 AMORTISATION At 1 Dècember 2021 Charge for the year 39 40 18 79 18 At 30 November 2022 39 58 97 NET BOOK VALUE At 30 November 2022 28 28 At 30 November 2021 46 Page 31 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 14. TANGIBLE FIXED ASSETS GROUP AND CHARrrY Long-tsrni 1oas8hold Fixlures and property fittings £000 £000 Freghold propgrty Computer equipment £000 Total £000 COST OR VALUATION At 1 December 2021 Additions Disp05als 6A24 330 118 77 63 6,682 346 {41) 114) 1271 At 30 November2022 6.754 118 70 6,987 DEPRECIATION At 1 December 2021 Charge for the year On disposals 469 72 37 41 11 271 571 100 {411 11 1141 AI 30 November 2022 541 35 29 25 630 NET BOOK VALUE At 30 November 2022 6.213 83 41 20 6,357 AI 30 November 2021 5,955 4Q 22 6,111 It is Penny Brohn Cancer Care's rxiliGy to revalue freehold property every 5 years. The freehold property was revalued in August 2019 by Jones Lang Lasalle Limited, a fim) of valuers external to the Charity. The propertys open market value was considered to be £6,100,000 in a¢¢ordance wilh the RICS valuation mc*el. The carrying amount under the cost model of the assets which have been revalued would have been £6,045,00012021- £6,045,000). Page 32 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 15. FIXED ASSET INVESTMENTS Llsted Investments £000 GROUP COST OR VALUATION Al 1 December 2021 AT 30 NOVEMBER 2022 NET BOOK VALUE AT 30 NOVEMBER 2022 AT 30 NOVEMBER 2021 Llsted Investments £000 CHARITY COST OR VALUATION At 1 December 2021 AT 30 NOVEMBER 2022 NET BOOK VALUE AT 30 NOVEMBER 2022 AT 30 NOVEMBER 2021 16. STOCKS Group 2022 £000 18 Group 2021 £000 21 Finished goods and goods for ￿$￿e Page 33 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 17. DEBTORS Group 2022 Group 2021 £000 Charkty 2022 £000 Charity 2021 £000 DUE WITHIN ONE YEAR Trade debtors Amounts owed by group undertakings Other debtors Prepayments and accrued income 217 194 201 288 41 85 188 28 39 85 155 155 341 356 615 378 Page 34 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 18. CREDITORS: AMOUNTS FALLING DUE wrrHIN ONE YEAR Group 2022 £000 Group 2021 £000 Charlty 2022 £000 Charity 2021 £000 Bank loans Other loans Trade creditors Other taxation and social security Other creditors Aecruals and deferred income 61 10 81 68 19 102 72 61 10 76 72 78 28 16 92 71 27 14 91 17 102 341 286 301 275 Facilities wth Natwesl Bank and Triodo$ Bank, secured on the freehold property of the Charity, are in place. Group 202Z £000 Group 2021 £000 Deferred incom8 al 1 December 2021 Resou￿5 deferred during the year Amounts released from previous periods 41 19 41 1191 (391 11 41 19. CREDITORS: AMOUNTS FALLING DUE AFfER MORE THAN ONE YEAR Group 2022 £000 Group 2021 £000 Charlty 2022 £000 Charty 2021 £000 Bank loans Other loans 894 31 908 39 31 39 925 947 925 947 The aggregate amount of liabilities payable or repayable Whol￿ or in part more than five years after the reporting date is.. Group 2022 £000 Group 2021 £000 Charity 2022 £000 Charity 2021 £000 Payable or repayable by instalments 636 636 664 636 664 636 664 Page 35 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 20. STATEMETr¥f OF FUNDS STATEMENT OF FUNDS- CURRENT YEAR Balance at 1 Decembgr 2021 £000 Transfers Balance at 30 Inlout November 2022 £000 £000 Income Expendlture £000 £000 UNRESTRICTED FUNDS DESIGNATED FUNDS Capital fund 5.112 257 (100) 5.269 GENERAL FUNDS General fvnd PB UK Commercial Ltd Revaluation reserve 1,IJ03 1.665 237 12.216) 1310) 12611 191 {72) S5 55 TOTAL GENERAL FUNDS 1,059 1.902 (2.526) (2611 174 TOTAL UNRESTRICTED FUNDS 6,171 2,159 (2,626) {2611 RESTRICTED FUNDS Bristol Whole Lrfe Approach in Scouand Buildings at National Centre Client Insight Communlty Engagernent Garden 12 {11 {5> (25> (50> (10> 11 25 Homeopathic pilot Library Residential Retreats & Wellbeing Days Living Well programme Lymphodeoma Nutn'tion Onè to One Other small dtsnab.ons Penny Brohn on the High Street Regional donats'ons Relaxation chairs Rernote services Treatment support Trust income 16 13> (20) 13 261 261 (4) 18) 14) 14) (9) 11 2S 30 61 39 31 10 {59) (9) (2) TOTAL RESTRICTED FUNDS 212 {213) 261 375 Page 36 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 20. STATEMENT OF FUNDS {coTrillNUED) Capital Fund The capital fund represents the net book value of fixed assets, less loans secured on the freehold property plus the revaluation ￿serVe. Restrfcted funds Restricted to Dumfrlgs Housg, Scotland The Bristol Whole Life Approach in Scotland is a pilot project to work in partnership with Dumfrles House in Ayrshire, giving us the chance lo take our 8ristol Whote Life Approach lo men and women living wrth can￿r in Scolland. R8strlct8d to Bulkllngs at the Natk)nal Cgntro Funds were received from The Postcode Local Trust to help re-open the National Centre post COVID for both ¢ommerual venue hire and this year for people with cancer. Re$trl¢ted to Communlty Engagement This income from The Prince ol Wales Foundation was re-purposed. fc41owng discussion with the Foundation, to other projects and core services during this financial year. Restrlctgd to Garden Funds were received frorn The Clatk FoundatN)n for the purchase garden fumiture. We received a private dDnab"on for pay for the repair of the Folty. Funds raised from plant sales al the NGS open garden day are reinvested into our Therapeutic Gardens. Waitrose Community Funds made a donats'on to be used within our green Space. Restricted to tha Homeopathic Project A grant was received from Nelsons for the provision of online consultab'ons with a qualffied Homeopath which will be utilised in 2023. Restricted to Library The library fund contains a grant for updating resour(xs, shelving and IT within the James Tudor Library. The grant was provided by the James Tudor Foundation. Restrlcted to Residential Retreats Funds were received in 2021 and 2022 for clients to attend Residential Retreais and Wellbeing Days. Ro$trfeted to Lymphodoema A restricted legacy was received in 2018 to make special fa￿litIeS available to those dients suffering with Lymphodoema. This legacy was InC￿rreC￿ appothoned to general funds in previous accounts, so an adjustrnenl was made in this set ot accounts lo appoth'on the legacy to restricted ftjnds. Restricted to Nutrition Funds were received in 2021 from The James Tudor Foundation to help fund the new role ol Nutrition & Communications Coordinator which supports the regular review and update of the evidenoe that underpins our approach lo dieL nutrition and supplementary treatment for people living with cancer. Restrfcted to One to One's Fund were re￿iVed lo cover the cost of providing one lo one appointment's with an inlegralive doolor. Grants were provided by The Weinstock Fund, The Pink Ribbon Foundab"on and St James Place. Restrict8d to Pénny Brohn on the High Steet Kr￿wn as'The Hub,, restricled funds were had been receNed from the Newby Charitable Trust to provide Psychological services at The Hub. Due to Comd restrictions, this service provision did not start until this current year when we were abie to start proving to la￿ Services. The John James frjundats'on have provided a grant to $ubsidi$e non-salary costs at The Hub for the Page 37 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 20. STATEMENT OF FUNDS ICONTINUEDI 2022r23 financial year. The aim of the Hub. is to build visibility within communities but creating a high street destination offering Liwng Well services and self-managemenl resour*s alongside the more tradffcional donated good shop rnodel. Rogional Donations Funds were received from several trusts including Waller Guiness Charitable Trust, Scott Bader, L & T Bmmll Foundation, Lill￿ Johnson Charitable Trust to provide remote sUPPOrt t¢ people living across the UK. Restrlctsd to Rolaxatlon Chalrs The Relaxation chairs fvnd is a grant to enable us to upgrade and replace our relaxation chairs. Restrlctsd to Romots Servlces We continue to provide our programme of online support throughout the year with national reach, for people affected by cancer expanding our offering. These funds have enabled us to grow this service and embed it as part of the hybrid Serv￿ model we have going forward. Grants have been reTrived from Gerald miC￿em charitab￿ Trust The February Foundation and The Tim Tiley Bursary Fund. Restrlcted to Treatment Support The Treatment Support fijnd contains donations to cover the cost of providing our Online Treatment Support Programme. During 2022 this was supported by grants from The Florence Shute Millennium Trust, Kevin Dawes and The Weinstock Fund. STATEMENT OF FUNDS- PRIOR YEAR Balan￿ at 1 De￿mber 2020 Balance at Transfers 30 November inlout 2021 £000 £000 Income Expenditure £000 £000 UNRESTRICTED FUNDS DESIGNATED FUNDS Capital fund S,213 (101) 5,112 GENERAL FUNDS General fund Shop@PennyBrohn Ltd Revaluation reserve 878 2,035 65 12,013) 168) 103 1,003 55 55 TOTAL GENERAL FUNDS 937 2,100 12,0811 103 1,059 TOTAL UNRESTRICTED FUNDS 6.150 2,100 {2,1821 103 6,171 RESTRICTED FUNDS Tim riley Bursary fund Living Well programme Treatment support Digitsl Discovery Relaxation chairs (3} 20 20 (11 (121 12 Page 38 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 20. STATEMENT OF FUNDS IcoHfiNUEDI STATEMENT OF FUNDS - PRIOR YEAR (CONTINUED) Balance at 30 November 2021 £000 Balance al 1 December 2020 £000 Tmnsfers inloul £000 Income Expenditure £000 £OOD Garden Nutrition al Penny Brohn Buildings at National Centre Bristol Whole Life Approach in Scotland Living Well - Nath"onal Community engagement Pre-treatment support dinic at BHOC Remote services Penny Brohn on the High Streel Trust income Other small donations Restricted to Client Insight One to One 15 {11 13 (11 12 le 50 14 100 80 131 191 181 {51 1127) 47 39 25 40 {10) 25 25 15} TOTAL RESTRICTED FUNDS 186 185 156) 11031 212 TOTAL OF FUNDS 6,3 2,285 {2,238) 6,383 21. ANALYSIS OF NET ASSETS BETWEEN FUNDS ANALYSIS OF NEf ASSETS BETWEEN FUNDS- cuRRETr￿ YEAR Unrestricted Restricted funds funds 2022 2022 £000 Total funds 2022 £000 Tangible fixed assets Intangible fixed assels Fixed asset investments Current assets credito￿ due within one year Crèditors due in more than one year 6,357 29 6,357 29 316 375 691 (341 > (925} 13411 19251 TOTAL 5.443 375 5,818 Page 39 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 21. ANALYSIS OF NET ASSETS BETWEEN FUNDS (CONTINUED) ANALYSIS OF NET ASSETS BETWEEN FUNDS- PIUOR YEAR Unreslrieted fijnds 2021 £000 Restricted funds 2021 £000 Total funds 2021 £000 Tangible fixed assets Intangible fixed asset5 Fixed asset investments Curre￿1 assets Creditors due within one year Creditors due in more than one year 6,111 46 6,111 46 1,240 1286) 1947} 212 1,452 12861 19471 TOTAL 6,171 212 6,383 RECONCILIATION OF NET MOVEME1￿ IN FUNDS TO NET CASH FLOW FROM OPERATING ACTNMES 22. Group 2022 £000 Group 2021 £000 Net incomelexpenditure for the year {as per Statement of Financial Activities) 1564) 47 ADJUSTMENTS FOR: Depreciation charges Amorti5ab'on charges Decreasellincrease) in stocks Decreasellincreasel in debtors Increasel{decreasel in creditors Interest paid 100 18 102 17 181 1116} 126} 25 1S 55 NET CASH PROVIDED BYIIUSED IN) OPERATING ACTIVMES {3191 41 23. ANALYSIS OF CASH AND CASH EQUIVALETrrrs Group 2022 £000 332 Group 2021 £000 Cash in hand 1,075 TOTAL CASH AND CASH EQUIVALENTS 332 1,075 Page 40 PENNY BROHN CANCER CARE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2022 24. ANALYSIS OF CHANGES IN NET DEBT At1 December 2021 Cash flows £000 At30 Novpmber 2022 £000 £000 1,075 {721 (947) Cash at bank and in hand Debt due within 1 year Debt due after 1 year (744) 331 (711 {925} 22 1721} 166S) 25. RELATED PARTY TRANSACTIONS Trustees, remuneration and expenses 1$ detailed in note 12. Trustees are able to make use of the accomodation at the National Centre when attending on business and usually provide a donation in respect of this. No Trustees were provided any nights accomodation the year12021. nill. Donations from trustees and related parknes an￿Unted lo £1.470 during the year12021: £2,170), Page 41